NASDAQ: EHTHEhealth Inc Stock
$5.46-0.03 (-0.55%)
Updated May 17, 2024
EHTH Price
$5.46
Fair Value Price
N/A
Market Cap
$159.01M
52 Week Low
$4.28
52 Week High
$10.31
P/E
-2.36x
P/B
0.27x
P/S
0.37x
PEG
N/A
Dividend Yield
N/A
Revenue
$472.11M
Earnings
-$25.32M
Gross Margin
99.7%
Operating Margin
-2.47%
Profit Margin
-14%
Debt to Equity
0.35
Operating Cash Flow
$3M
Beta
1.29
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
EHTH Overview
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company operates a marketplace that offers consumers a choice of insurance products, such as Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business, and other ancillary health insurance products from health insurance carriers. It markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers to market and distribute health insurance plans online; and provides online sponsorship and advertising, and lead referral services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EHTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EHTH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EHTH is good value based on its book value relative to its share price (0.27x), compared to the US Insurance Brokers industry average (7.02x)
P/B vs Industry Valuation
EHTH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more EHTH due diligence checks available for Premium users.
Be the first to know about important EHTH news, forecast changes, insider trades & much more!
EHTH News
Valuation
EHTH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.36x
Industry
30.64x
Market
30.97x
EHTH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.27x
Industry
7.02x
EHTH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EHTH's financial health
Profit margin
Revenue
$93.0M
Net Income
-$17.0M
Profit Margin
-29.8%
EHTH's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
EHTH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.1B
Liabilities
$205.4M
Debt to equity
0.35
EHTH's short-term assets ($404.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EHTH's short-term assets ($404.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EHTH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EHTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$70.8M
Investing
-$10.3M
Financing
-$1.3M
EHTH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
EHTH vs Insurance Stocks
Ehealth Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.